The miRNA target genes. by Zhaowen Tan (12283502)

“…</p><p>Results</p><p>1) Hemodynamic tests revealed that the blood pressure of SHRs in the BFRT decreased significantly and that the blood pressure level of SHRs in the BFRT decreased more significantly than that of the simple resistance training groups did (P < 0.05). 2) Cardiac function tests revealed that the EF, FS, and MV E/A of SHRs in the BFRT significantly increased, whereas the HR, IVSd, IVSs, LVIDd, LIVDs, LVPWd, LVPWs and LV mass significantly decreased (P < 0.05). 3) Transcriptome sequencing revealed 9 differentially expressed miRNAs in the BFRT group compared with the SHR-SED group (2 miRNAs were significantly upregulated, and 7 miRNAs were significantly downregulated), with P < 0.05 and |log2FoldChange| ≥ 1 used as the criteria for differential significance. …”

Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Lower quartile of district towns evaluated by the SD-TOPSIS technique ‐ combination of A, B1, B1 and C1. by Roman Vavrek (13200141)

Changes in health-related quality of life indexes before and after disease onset. by Ji Woong Chang (1829314)

Subjects:

Differences in health-related quality of life indexes after disease onset between groups. by Ji Woong Chang (1829314)

Subjects:

Demographic characteristics of the participants. by Ji Woong Chang (1829314)

Subjects:

Data file. by Ji Woong Chang (1829314)

Subjects:

Amphiphilic Photoluminescent Porous Silicon Nanoparticles as Effective Agents for Ultrasound-Amplified Cancer Therapy by Maxim B. Gongalsky (6527933)

Subjects:

Growth and metabolic characteristics of strain VROV1 in vanadate-free (upper panels) and vanadate-containing (lower panels) media. by Bokyung Kim (622579)

Overview of the parameters used in the model. by Albertus Constantijn Sloof (20405090)

“…Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …”

Mortality rates per lifecycle stage [28]. by Albertus Constantijn Sloof (20405090)

“…Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …”

The results of linear mixed model. by Soheila Qanbari (20455173)

Subjects:

The flow of the participants from enrollment to analysis. by Soheila Qanbari (20455173)

Subjects:

Correlation between treatment-induced changes in lumbar motor control and N150 amplitude. by Soheila Qanbari (20455173)

Subjects:

Sensory-evoked potentials of N80 and N150. by Soheila Qanbari (20455173)

Subjects:

The mean and standard deviation of outcome measures. by Soheila Qanbari (20455173)

Subjects:

Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. by Soheila Qanbari (20455173)

Subjects:

The demographical and clinical characteristics of subjects at baseline. by Soheila Qanbari (20455173)

Subjects:

Electrode montage and electric field distribution simulated with SimNIBS software. by Soheila Qanbari (20455173)

Subjects:

Clinical data of dogs and comparisons among groups. Values are distributed into 4 groups based on the value of the perfusion index (PI). Groups P1, P2, P3, and P4 included measurem... by Francesca Zanusso (18864843)